Urinary Tract Infections in Adult General Practice Patients

Overview

Journal Br J Gen Pract

Specialty Public Health

Date 2002 Sep 19

PMID 12236281

Citations 22

Authors

Eva Hummers-Pradier

Michael M Kochen

Affiliations

Soon will be listed here.

Abstract

Urinary tract infections (UTIs) are symptomatic infections of the urinary tract, mainly caused by the bacterium Escherichia coli. One in two women suffers from a UTI at least once in her life. The young and sexually active are particulaly affected, but it is also seen in elderly, postmenopausal women. The likelihood of recurrence is high. Diagnosis is made with regard to typical complaints and the presence of leucocytes and nitrites in the urine. A culture is unnecessary in most cases. Uncomplicated UTI should be distinguished from complicated UTI, which has a risk of severe illness. The treatment of choice--short-term therapy with trimethoprim or nitrofurantoin--is successful in over 80% of the cases. Co-trimoxazol fluoroquinolones or cephalsporins are not considered first-choice drugs. There are indications that general practitioners' (GPs') management of UTI is not always optimal, specifically concerning diagnostic tests, the application of second-choice antibiotics, and the length of prescribed treatment courses. Many points relevant to GPs requirefurther research, such as epidemiology and resistance of urinary pathogens in the community and natural history of UTI, as well as optimal management in elderly or complicated patients and men.

Citing Articles

Severity and Bothersomeness of Urinary Tract Infection Symptoms in Women before and after Menopause.

Teglbraender-Bjergkvist S, Siersma V, Holm A Antibiotics (Basel). 2023; 12(7).

PMID: 37508244 PMC: 10376207. DOI: 10.3390/antibiotics12071148.

Prevalence and Antimicrobial Sensitivity Patterns of Uropathogens, in Tikur Anbessa Specialized Hospital Emergency Medicine Department Addis Ababa, Ethiopia.

Firissa Y, Shelton D, Azazh A, Engida H, Kifle F, Debebe F Infect Drug Resist. 2023; 16:1649-1656.

PMID: 36992968 PMC: 10041979. DOI: 10.2147/IDR.S402472.

Routine laboratory surveillance of antimicrobial resistance in community-acquired urinary tract infections adequately informs prescribing policy in England.

Watts V, Brown B, Ahmed M, Charlett A, Chew-Graham C, Cleary P JAC Antimicrob Resist. 2021; 2(2):dlaa022.

PMID: 34222986 PMC: 8210191. DOI: 10.1093/jacamr/dlaa022.

Stimulation of de novo glutathione synthesis by nitrofurantoin for enhanced resilience of hepatocytes.

Wijaya L, Rau C, Braun T, Marangoz S, Spegg V, Vlasveld M Cell Biol Toxicol. 2021; 38(5):847-864.

PMID: 34021431 PMC: 9525367. DOI: 10.1007/s10565-021-09610-3.

Construction of a patient decision aid for the treatment of uncomplicated urinary tract infection in primary care.

Vincent Y, Frachon A, Buffeteau C, Conort G BMC Fam Pract. 2021; 22(1):26.

PMID: 33499824 PMC: 7839208. DOI: 10.1186/s12875-021-01374-3.

References

Rink E . Risk factors for urinary tract symptoms in women: beliefs among general practitioners and women and the effect on patient management. Br J Gen Pract. 1998; 48(429):1155-8. PMC: 1410053. View

Christiaens T, Heytens S, Verschraegen G, De Meyere M, De Maeseneer J . Which bacteria are found in Belgian women with uncomplicated urinary tract infections in primary health care, and what is their susceptibility pattern anno 95-96?. Acta Clin Belg. 1998; 53(3):184-8. View

Omar H, Aggarwal S, Perkins K . Tampon use in young women. J Pediatr Adolesc Gynecol. 1998; 11(3):143-6. DOI: 10.1016/s1083-3188(98)70134-2. View

Zhanel G, Karlowsky J, Schwartz B, Jensen S, Hoban D . Mecillinam activity compared to ampicillin, trimethoprim/sulfamethoxazole, ciprofloxacin and nitrofurantoin against urinary tract isolates of gram-negative bacilli. Chemotherapy. 1998; 44(6):391-6. DOI: 10.1159/000007149. View

Brumfitt W, Hamilton-Miller J . Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience. J Antimicrob Chemother. 1998; 42(3):363-71. DOI: 10.1093/jac/42.3.363. View

Preston S, Abdel-Rahman S, Nahata M . Empiric treatment of uncomplicated urinary tract infections. Ann Pharmacother. 1998; 32(11):1231-3. DOI: 10.1345/aph.16411. View

Schaeffer A, Stuppy B . Efficacy and safety of self-start therapy in women with recurrent urinary tract infections. J Urol. 1999; 161(1):207-11. View

Gupta K, Scholes D, Stamm W . Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 1999; 281(8):736-8. DOI: 10.1001/jama.281.8.736. View

McCarty J, Richard G, Huck W, TUCKER R, Tosiello R, Shan M . A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group. Am J Med. 1999; 106(3):292-9. DOI: 10.1016/s0002-9343(99)00026-1. View

10.

Iravani A, Klimberg I, Briefer C, Munera C, Kowalsky S, Echols R . A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. J Antimicrob Chemother. 1999; 43 Suppl A:67-75. View

11.

Osterlund A, Olsson-Liljequist B . [Fluoroquinolone resistance of human pathogenic bacteria. Resistant E coli now appearing in Sweden]. Lakartidningen. 1999; 96(16):1965-6. View

12.

Baerheim A, Digranes A, Hunskaar S . Are resistance patterns in uropathogens published by microbiological laboratories valid for general practice?. APMIS. 1999; 107(7):676-80. DOI: 10.1111/j.1699-0463.1999.tb01458.x. View

13.

Wigton R, Longenecker J, Bryan T, Parenti C, Flach S, Tape T . Variation by specialty in the treatment of urinary tract infection in women. J Gen Intern Med. 1999; 14(8):491-4. PMC: 1496718. DOI: 10.1046/j.1525-1497.1999.05398.x. View

14.

Fowler Jr J, Pulaski E . Excretory urography, cystography, and cystoscopy in the evaluation of women with urinary-tract infection: a prospective study. N Engl J Med. 1981; 304(8):462-5. DOI: 10.1056/NEJM198102193040805. View

15.

Baerheim A, Digranes A, Hunskaar S . Equal symptomatic outcome after antibacterial treatment of acute lower urinary tract infection and the acute urethral syndrome in adult women. Scand J Prim Health Care. 1999; 17(3):170-3. DOI: 10.1080/028134399750002593. View

16.

WARREN J, Abrutyn E, Hebel J, Johnson J, Schaeffer A, Stamm W . Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis. 1999; 29(4):745-58. DOI: 10.1086/520427. View

17.

Hummers-Pradier E, Denig P, Oke T, Lagerlov P, Wahlstrom R, Haaijer-Ruskamp F . GPs' treatment of uncomplicated urinary tract infections--a clinical judgement analysis in four European countries. DEP group. Drug Education Project. Fam Pract. 2000; 16(6):605-7. DOI: 10.1093/fampra/16.6.605. View

18.

Veninga C, Lundborg C, Lagerlov P, Hummers-Pradier E, Denig P, Haaijer-Ruskamp F . Treatment of uncomplicated urinary tract infections: exploring differences in adherence to guidelines between three European countries. Drug Education Project Group. Ann Pharmacother. 2000; 34(1):19-26. DOI: 10.1345/aph.19068. View

19.

Nicolle L . Pivmecillinam for the treatment of acute uncomplicated urinary infection. Int J Clin Pract. 2000; 53(8):612-7. View

20.

Delzell Jr J, LeFevre M . Urinary tract infections during pregnancy. Am Fam Physician. 2000; 61(3):713-21. View